US Pharma MarketingRoche is set to pay out a little more than $1 billion to acquire digital pathology specialist Path AI in a move the pharma giant hopes will bolster the use of artificial intelligence in diagnostic algorithms.
Roche shells out up to $1B for PathAI in move to boost artificial intelligence-powered diagnostics
Roche shells out up to $1B for PathAI in move to boost artificial intelligence-powered diagnostics is a pharma and life sciences industry update from FierceBiotech. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: FierceBiotech